01868-A: Development of a Novel System for Controlled Drug Delivery in the Dog
Grant Status: Closed
Abstract
Titanium (Ti) implant is a widely used implant materials. There are numerous Ti implant surgeries performed in both human and animals each year. In this proposal, Dr. Kerr will develop an innovative drug carrier to control drug release for canine implant surgery applications (e.g. orthopedic and dental). The drugs under investigation in this proposal are gemcitabine, carpofen and lidocaine due to their importance in canine implant surgeries. This innovative drug carrier will be synthesized by developing a coating of biodegradable polymer filled TiO2 nanotubes on Ti implant surface. If this novel drug carrier is successful, it will have broad application for treatment of common canine diseases such as hip and elbow dysplasia, osteosarcoma and enhanced wound healing after surgery.
Publication(s)
Help Future Generations of Dogs
Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.
